Accessibility Menu

Bayer Aktiengesellschaft

(FRA) BAYN

Current Price€48.46
Market Cap€47.61BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1992)+868%
5 Year-4%
1 Year+73%
1 Month+28%
Bayer Aktiengesellschaft last closing stock price
MetricPriceDate
Last closeEUR 48.462026-07-17
Bayer Aktiengesellschaft stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-3.31%EUR 50.122026-07-10
1 month+28.4%EUR 37.742026-06-17
3 month+17.91%EUR 41.102026-04-17
Year to date+30.94%EUR 37.012025-12-30
1 year+73.26%EUR 27.972025-07-17
3 year-5.72%EUR 51.402023-07-18
5 year-4.36%EUR 50.672021-07-16
Since inception+867.54%EUR 5.011992-01-01

Bayer Aktiengesellschaft Financials at a Glance

Market Cap

€47.61BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€45.24K

Net Income (TTM)

-€2.13K

EPS (TTM)

-€2.19

P/E Ratio

-22.08

Dividend

€0.11

Beta (Volatility)

-0.07 (Low)

Price

€48.46

Volume

3,583

Open

€47.32

Previous Close

€48.46

Daily Range

€46.88 - €48.46

52-Week Range

€24.89 - €53.74

Estimated Earnings Date

N/A

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Bayer Aktiengesellschaft

Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Industry

Pharmaceuticals

Employees

87,757

CEO

William N. Anderson

BAYN Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-7.04%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-4.53%

Dividend Yield

0.23%

Payout Ratio

N/A

Stock Overview

Market Cap

€47.61BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

982.42M

Volume

3.58K

Avg. Volume

9.82K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Bayer Aktiengesellschaft Performance Analysis

Bayer Aktiengesellschaft annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31EUR 50,739,000,00015.1%
20232023-12-31EUR 47,637,000,000-6.1%
20242024-12-31EUR 46,606,000,000-2.2%
20252025-12-31EUR 45,575,000,000-2.2%
Bayer Aktiengesellschaft annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31EUR 4.22315.0%
20232023-12-31EUR -2.99N/A
20242024-12-31EUR -2.60-13.2%
20252025-12-31EUR -3.6841.8%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

€13.41K

+1.0%

Gross Profit

€8.17K

+1.0%

Gross Margin

60.97%

+1.0%

Market Cap

€47.61BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

€0.45

+1.9%

Employees

87,757

+1.0%

Net Income

€2.77K

+2.1%

EBITDA

€4.37K

+1.0%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

€44.62K

+2.8%

Total Debt

€38.89K

+1.0%

Accounts Receivable

€12.91K

+1.0%

Inventory

€12.01K

+0.9%

Long Term Debt

€30.68K

+0.9%

Short Term Debt

€8.20K

+1.9%

Return on Assets

-1.99%

+0.7%

Return on Invested Capital

-1.41%

+0.3%

Free Cash Flow

-€2.32K

+1.5%

Operating Cash Flow

-€1.91K

+1.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,457.69-0.01%
^DJIDJI
$52,146.42-0.01%
^IXICNASDAQ
$25,520.24-0.01%
BTCBitcoin
$64,502.00+0.01%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$95.04-0.02%
PATHUiPath
$12.15+0.01%
JOBYJoby Aviation
$7.23-0.01%
TAT&T
$21.81-0.01%

Questions About BAYN

What is the current price of Bayer Aktiengesellschaft?

Bayer Aktiengesellschaft is trading at €48.46 per share.

What is the 52-week range for Bayer Aktiengesellschaft?

Over the past 52 weeks, Bayer Aktiengesellschaft has traded between €24.89 and €53.74.

How much debt does Bayer Aktiengesellschaft have?

As of the most recent reporting period, Bayer Aktiengesellschaft reported total debt of €38.89B.

How much cash does Bayer Aktiengesellschaft have on hand?

Bayer Aktiengesellschaft reported €5.73B in cash and cash equivalents in its most recent financial results.

What is Bayer Aktiengesellschaft’s dividend yield?

Bayer Aktiengesellschaft currently has a dividend yield of 0.23%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.